N-21

Active substance: CALCIUM FLUORIDE, SILICON DIOXIDE, EUPHRASIA STRICTA, RUTA GRAVEOLENS WHOLE, GELSEMIUM SEMPERVIRENS WHOLE, PHYSOSTIGMA VENENOSUM WHOLE, ANEMONE PULSATILLA, SODIUM CHLORIDE, SUS SCROFA EYE

SOLUTION · CALCIUM FLUORIDE 6 [hp_X]/mL, SILICON DIOXIDE 6 [hp_X]/mL, EUPHRASIA STRICTA 6 [hp_X]/mL, RUTA GRAVEOLENS WHOLE 6 [hp_X]/mL, GELSEMIUM SEMPERVIRENS WHOLE 6 [hp_X]/mL, PHYSOSTIGMA VENENOSUM WHOLE 4 [hp_X]/mL, ANEMONE PULSATILLA 8 [hp_X]/mL, SODIUM CHLORIDE 12 [hp_X]/mL, SUS SCROFA EYE 200 [hp_X]/mL

United StatesActive

Marketing holder: DNA Labs, Inc.

Verified 2026-10-09 · openFDA NDC

Source: openFDA NDC
Countries with the substance registered: 1

Composition

CALCIUM FLUORIDE · 6 [hp_X]/mL
SILICON DIOXIDE · 6 [hp_X]/mL
EUPHRASIA STRICTA · 6 [hp_X]/mL
RUTA GRAVEOLENS WHOLE · 6 [hp_X]/mL
GELSEMIUM SEMPERVIRENS WHOLE · 6 [hp_X]/mL
PHYSOSTIGMA VENENOSUM WHOLE · 4 [hp_X]/mL
ANEMONE PULSATILLA · 8 [hp_X]/mL
SODIUM CHLORIDE · 12 [hp_X]/mL
SUS SCROFA EYE · 200 [hp_X]/mL

Registration

Registration number: 58264-0219
Registration status: Active
Dispensing: Over the counter
Route: SUBLINGUAL

Sources

product · openFDA NDC · 58264-0219 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 58264-0219 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 58264-0219 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 58264-0219 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 58264-0219 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 58264-0219 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 58264-0219 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 58264-0219 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 58264-0219 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 58264-0219 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 58264-0219 · Verified 2026-10-09 · open in source